Bogle Investment Management’s Idexx Laboratories IDXX Stock Holding History

Bogle Investment Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-7,373	Closed	-$2.9M	–	202
2020 Q3	$2.9M	Sell	7,373 -8,154	-53%	-$3.01M	0.85%	51
2020 Q2	$5.13M	Sell	15,527 -28,083	-64%	-$8.13M	0.85%	7
2020 Q1	$10.6M	Buy	+43,610	New	+$11.4M	1.1%	20
2018 Q3	–	Sell	-32,001	Closed	-$6.97M	–	300
2018 Q2	$6.97M	Sell	32,001 -36,847	-54%	-$7.59M	0.5%	81
2018 Q1	$13.2M	Buy	+68,848	New	+$12.7M	0.99%	25
2017 Q2	–	Sell	-81,132	Closed	-$12.5M	–	342
2017 Q1	$12.5M	Buy	+81,132	New	+$11.2M	0.87%	35
2016 Q4	–	Sell	-99,112	Closed	-$11.2M	–	362
2016 Q3	$11.2M	Buy	+99,112	New	+$10.4M	0.81%	37

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return

Bogle Investment Management's IDXX Position: Q4 2020 in Review

Bogle Investment Management sold out of Idexx Laboratories (IDXX) in Q4 2020, closing a stake of 7,373 shares — an estimated $2.9M sold.

Bogle Investment Management first reported a position in IDXX in Q3 2016 and held it in 7 quarters. The position peaked at $13.2M in Q1 2018. 971 funds tracked by Wall St. Rank hold IDXX as of Q4 2020.

Bogle Investment Management reported no remaining Idexx Laboratories position as of Q4 2020 after selling out during the quarter.
Bogle Investment Management sold 7,373 Idexx Laboratories shares in Q4 2020, an estimated $2.9M.
Bogle Investment Management first reported a position in Idexx Laboratories in Q3 2016 and held it in 7 quarters.
Bogle Investment Management's Idexx Laboratories position peaked at $13.2M in Q1 2018.
971 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2020.

Based on Bogle Investment Management's 13F filing for Q4 2020, filed 12 Feb 2021.